Massive omental reticuloendothelial cell lipid uptake in tangier disease after splenectomy

Fredrickson, 1961, 55, 1016 Fredrickson, 1964, The inheritance of high density lipoprotein deficiency (Tangier disease), J Clin Invest, 43, 228, 10.1172/JCI104907 Hoffman, 1965, Tangier disease (familial high density lipoprotein deficiency): clinical and genetic features in two adults, Am J Med, 39, 582, 10.1016/0002-9343(65)90081-1 Engel, 1967, Neuropathy in Tangier disease:high density-lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage, Arch Neurol, 17, 1, 10.1001/archneur.1967.00470250005001 Heinen, 1978, Properties of plasma very low and low density lipoproteins in Tangier disease, J Clin Invest, 61, 120, 10.1172/JCI108910 Ferrans, 1975, The pathology of Tangier disease: a light and electron microscopic study, Am J Pathol, 78, 101 Herbert, 1982, Familial lipoprotein deficiency (abetalipoproteinemia, hypobetalipoproteinemia and Tangier disease), 589 Chu, 1979, Ocular manifestations of familial high density lipoprotein deficiency (Tangier disease), Arch Ophthalmol, 97, 1926, 10.1001/archopht.1979.01020020374020 Waldorf, 1967, Cutaneous cholesteryl ester deposition in Tangier disease, Arch Dermatol, 95, 161, 10.1001/archderm.1967.01600320017003 Assmann, 1977, The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins, J Clin Invest, 59, 565, 10.1172/JCI108672 Henderson, 1978, Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease, Metabolism, 27, 165, 10.1016/0026-0495(78)90162-2 Alaupovic, 1981, Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease), Metabolism, 30, 805, 10.1016/0026-0495(81)90027-5 Schaefer, 1978, Metabolism of high density lipoprotein apolipoproteins in Tangier disease, N Engl J Med, 299, 905, 10.1056/NEJM197810262991701 Assmann, 1978, Apoprotein A metabolism in Tangier disease, Atherosclerosis, 30, 321, 10.1016/0021-9150(78)90125-9 Schaefer, 1981, The metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins, J Lipid Res, 22, 217, 10.1016/S0022-2275(20)35365-7 Kay, 1982, Tangier disease: a structural defect in apolipoprotein A-I, 79, 2485 Zannis, 1982, Abnormal apo A-I isoprotein composition in patients with Tangier disease, J Biol Chem, 257, 4978, 10.1016/S0021-9258(18)34621-0 Schaefer, 1982, Tangier disease: high density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-I (apo A-ITangiar), J Clin Invest, 70, 474, 10.1172/JCI110705 Summerfield, 1981, The molecular basis of Tangier disease a: structurally abnormal apolipoprotein A-I mediates hypercatabolism of lipoprotein by hepatocytes and accumulation of cholesterol in Kupffer cells (abstr), Hepatology, 1, 552 1974, vol 1 Schaefer, 1982, Human apolipoprotein A-I and A-II metabolism, J Lipid Res, 23, 850, 10.1016/S0022-2275(20)38087-1 Schaefer, 1980, Coronary heart disease prevalence and other clinical features in familial high density lipoprotein deficiency (Tangier disease), Ann Intern Med, 93, 261, 10.7326/0003-4819-93-2-261 Herbert, 1978, Tangier disease. One explanation for lipid storage, N Engl J Med, 299, 519, 10.1056/NEJM197809072991005 Schaefer, 1982, Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease, Arteriosclerosis, 2, 16, 10.1161/01.ATV.2.1.16